Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

INTRODUCTION: The lifetime incidence of nail psoriasis in patients with psoriasis is 80–90%, with 23–27% of patients having nail psoriasis at any given time. Nail psoriasis is even more prevalent in patients with comorbid psoriatic arthritis. Complete psoriasis clearance, an achievable therapeutic g...

Descripción completa

Detalles Bibliográficos
Autores principales: Elewski, Boni E., Blauvelt, Andrew, Gallo, Gaia, Wolf, Eric, McKean-Matthews, Missy, Burge, Russel, Merola, Joseph F., Gottlieb, Alice B., Guenther, Lyn C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021345/
https://www.ncbi.nlm.nih.gov/pubmed/35279805
http://dx.doi.org/10.1007/s13555-022-00704-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021345/
https://www.ncbi.nlm.nih.gov/pubmed/35279805
http://dx.doi.org/10.1007/s13555-022-00704-2

Ejemplares similares